| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/26/2006 | EP0773997B1 Htk ligand |
| 04/26/2006 | CN1764430A Kit for pharmaceutical use |
| 04/26/2006 | CN1763217A Preparation method of monoclonal antibody and application thereof |
| 04/26/2006 | CN1763216A Process for separating protein, apple polyphenol, apple starch and pigment from apple juice |
| 04/26/2006 | CN1763215A Process for preparing composite high-protein antibacterial peptide |
| 04/26/2006 | CN1763206A Scorpion toxin AaHIT1 gene sequence and application thereof |
| 04/26/2006 | CN1763190A Production method for recombinant cytoglobin and uses thereof |
| 04/26/2006 | CN1763105A Fusion protein for stimulating organism to produce FMDV antibody and its coding gene and uses |
| 04/26/2006 | CN1763097A Polypeptide variants with altered effector function |
| 04/26/2006 | CN1253575C Methods for producing a polypeptide using a consensus translational initiator sequence |
| 04/26/2006 | CN1253574C A fungus wherein areA gene has been modified and areA gene from aspergillus oryzae |
| 04/26/2006 | CN1253471C Type CC chemokine-like protein |
| 04/26/2006 | CN1253452C Thioether subsituted imidazoquinoline compound |
| 04/26/2006 | CN1253204C Biological process for the production of a food product comprising heme-iron and food product obtained with said process |
| 04/25/2006 | US7034137 Isolated mammalian membrane protein genes; related reagents |
| 04/25/2006 | US7034135 Isolated nucleic acids; culture product; binding to nucleotide; gene expression |
| 04/25/2006 | US7034125 Comprises neurotransmitter transport protein for monitoring and evaluating modulators of neuronal signaling; diagnosis and treatment of schizophrenia, epilepsy, depression, learning and neurodegenerative disorders |
| 04/25/2006 | US7034123 Anti-PRO1347 antibodies |
| 04/25/2006 | US7034122 Nucleotide sequences coding polypeptide for use in the treatment of nervous system and tumor disorders |
| 04/25/2006 | US7034121 Antibodies against CTLA4 |
| 04/25/2006 | US7034119 Method for recombinant production of polypeptides |
| 04/25/2006 | US7034118 Isolation nucleic acids; genetic engineering |
| 04/25/2006 | US7034114 Polypeptide for use in the treatment of inflammation, atherosclerosis, nervous system, blood, muscular, connective tissue and cancer disorders |
| 04/25/2006 | US7034108 Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof |
| 04/25/2006 | US7034002 Angiotensin converting enzyme inhibitor |
| 04/25/2006 | US7033992 Formulations for IL-11 |
| 04/25/2006 | US7033828 Nucleic acid encoding gamma retinoic acid receptor fusion protein |
| 04/25/2006 | US7033825 Nucleotide sequences coding polypeptide for use in the treatment of nephritis, cancer and kidney disorders |
| 04/25/2006 | US7033815 Biosynthesis of S-adenosylmethionine in a recombinant yeast strain |
| 04/25/2006 | US7033810 Sitosterolemia susceptibility gene (SSG): compositions and methods of use |
| 04/25/2006 | US7033807 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 04/25/2006 | US7033806 HY2 family of bilin reductases |
| 04/25/2006 | US7033799 Haemophilus adherence and penetration proteins |
| 04/25/2006 | US7033798 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment |
| 04/25/2006 | US7033797 for identification and vaccination of human papillomavirus; |
| 04/25/2006 | US7033796 cloned from cDNA library of human liver carcinoma cell line using PCR amplification; host cells |
| 04/25/2006 | US7033793 Genes and proteins can be used in making transgenic animals and in assays designed to determine the likelihood of an individual developing cardiomyopathy |
| 04/25/2006 | US7033791 Nucleic acid molecules encoding modified factor VIII proteins, expression products, and methods of making the same |
| 04/25/2006 | US7033790 Proteins and nucleic acids encoding same |
| 04/25/2006 | US7033788 Saxatilin isolated via gel fitration of venom from vipers, then performing high performance liquid chromatography; for use as anti-platelet aggregation agents and antitumor agents |
| 04/25/2006 | US7033787 For use in therapy |
| 04/25/2006 | US7033786 Identification and isolation of DNA and recombinant production of polypeptides |
| 04/25/2006 | US7033785 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders |
| 04/25/2006 | US7033783 Polynucleotide encoding IL-1 zeta polypeptide |
| 04/25/2006 | US7033781 gene knockout; for production of transgenic microbes, plants, progenitor cells |
| 04/25/2006 | US7033772 for altering calories available as fats and cirulating fatty acid levels; drug screening; organ specific |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033751 Comprises viral glycoprotein fusion with glutathione s-tranferase (GST) or thioredoxin for use as diagnostic tool in screening blood products for retroviral infection |
| 04/25/2006 | US7033744 Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof |
| 04/25/2006 | US7033597 Intracellular delivery of biological effectors |
| 04/25/2006 | US7033592 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
| 04/25/2006 | US7033591 use of a membrane fraction of gram-negative bacteria such as Klebsiella pnemoniae comprising proteoglycans in combination with anticancer treatment for immunostimulant and/or inducing an antitumor immune response in mammals including humans |
| 04/25/2006 | US7033590 Factor IX/factor IXa activating antibodies and antibody derivatives |
| 04/25/2006 | US7033589 γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/20/2006 | WO2006042109A2 An apparatus for and method of sampling and collecting powders flowing in a gas stream |
| 04/20/2006 | WO2006041934A2 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | WO2006041849A2 Methods and compositions for concentrating secreted recombinant protein |
| 04/20/2006 | WO2006041488A1 Immortalized hepatocytes |
| 04/20/2006 | WO2006041280A1 Novel regulation protein |
| 04/20/2006 | WO2006041225A1 Polynucleotide for production of recombinant protein by silkworm |
| 04/20/2006 | WO2006041211A1 Protein capable of binding to plasticizer |
| 04/20/2006 | WO2006041194A1 LINKER FOR CONSTRUCTING mRNA-PUROMYCIN-PROTEIN CONJUGATE |
| 04/20/2006 | WO2006041157A1 Method of immunizing animal, composition for immunization, method of producing antibody, method of producing hybridoma and method of producing monoclonal antibody |
| 04/20/2006 | WO2006040920A1 Method of evaluating ctl induction ability and screening method using the same |
| 04/20/2006 | WO2006026447A3 PRODUCTION OF TNFR-Ig FUSION PROTEIN |
| 04/20/2006 | WO2005118802A3 Targeting pseudotyped retroviral vectors |
| 04/20/2006 | WO2005089315A3 Methods and compositions related to skcg-1, a tumor suppressor gene |
| 04/20/2006 | WO2005047314A3 Fgf-beta binding and supported peptides |
| 04/20/2006 | US20060085870 Plant fungicide, pesticides, insecticides; insertion protease detectors; corn |
| 04/20/2006 | US20060084799 Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their use |
| 04/20/2006 | US20060084798 Members of the basic helix-loop-helix-PAS (bHLH-PAS)superfamily of transcription regulators; alpha -class hypoxia-inducible factors; circadian rhythm disorders; binding partners for circadian responsive factors; transcription stimulation of genes having an E-box transcription control element |
| 04/20/2006 | US20060084792 Versatile platform for nanotechnology based on circular permutations of chaperonin protein |
| 04/20/2006 | US20060084790 P-Rex1, a ptdins (3,4,5) p3-g-beta-gamma-regulated guanine-nucleotide exchange factor for rac |
| 04/20/2006 | US20060084619 mesencephalic astrocyte-derived neurotrophic factor polypeptide; shown to protect the survival of embryonic mesencephalic dopaminergic neurons in culture |
| 04/20/2006 | US20060084600 Human homologues of fused gene |
| 04/20/2006 | US20060084164 Bacteria, yeasts or filamentous fungi, producing a fusion protein containing a hydrophobin fused to a protein, an enzyme or part of an enzyme with enzymatic activity, wherein said hydrophobin or hydrophobin-like protein has an ability to partition in aqueous two-phase systems (ATPS) |
| 04/20/2006 | US20060084163 Plant-derived alkaline alpha-galactosidase |
| 04/20/2006 | US20060084162 Catalytic domains of beta(1,4)-galactosyltransferase I having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use |
| 04/20/2006 | US20060084148 April-a novel protein with growth effects |
| 04/20/2006 | US20060084147 Apo-2 receptor |
| 04/20/2006 | US20060084146 Method for cell-free protein synthesis using extract solution derived from insect cell |
| 04/20/2006 | US20060084145 sRAGE mimetibody, compositions, methods and uses |
| 04/20/2006 | US20060084144 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084142 tyrosine kinase; screening for inhibitors of PDGFRA; gastrointestinal stromal tumor (GIST) |
| 04/20/2006 | US20060084141 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin |
| 04/20/2006 | US20060084140 Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY39 |
| 04/20/2006 | US20060084139 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084138 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084137 Coagulation, mechanical agitation; filtration |
| 04/20/2006 | US20060084136 Production of fusion proteins by cell-free protein synthesis |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060084119 Preparing budding virus expressing mammalian transporter having transporter activity by culturing host cell infected with budding virus comprising gene encoding transporter and is recombinantly expressing transporter, expressing transporter on envelope of budding virus released from host cell, harvesting |
| 04/20/2006 | US20060084117 Galphaq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors |
| 04/20/2006 | US20060084112 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states |
| 04/20/2006 | US20060084102 Methods for determining precise HERG interactions by mutagenesis |
| 04/20/2006 | US20060084091 Methods and compositions for polypeptide engineering |
| 04/20/2006 | US20060084087 Using presence of myofibrillogenesis regulator 1 (MR-1) gene as diagnostic tool in detection of paroxysmal dystonic choreoathetosis |
| 04/20/2006 | US20060084086 Proteins, polynucleotides encoding them and methods of using the same |
| 04/20/2006 | US20060084085 Methods and compositions for modulating Bax-mediated apoptosis |